Reaction

Product Difficult To Swallow reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,016 reports · 16 co-occurring drugs

As of the last recalculation, Product Difficult To Swallow appears in 1,016 FAERS reports alongside 16 co-occurring drug terms. The strongest observed disproportionality signal is LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE (PRR 190.7).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Loperamide Hydrochloride And Dimethicone231190.7192.1
Ibuprofen Tablets, Coated6131.231.2
Ibuprofen Sodium6131.031.0
Ibuprofen And Diphenhydramine Citrate2825.325.3
Abiraterone Acetate4422.922.9
Patiromer1421.021.0
Ledipasvir And Sofosbuvir1819.519.5
Loperamide Hydrochloride3818.018.1
Rifaximin1413.913.9
Olaparib1110.910.9
Ranolazine59.99.9
Droxidopa109.69.6
Diclofenac Potassium59.59.5
Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Alafenamide48.28.2
Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Disoproxil Fumarate36.86.8
Sofosbuvir66.36.3

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.